Literature DB >> 16879786

The effect of whole organ pancreas transplantation and PIT on diabetic complications.

Timothy C Lee1, Neal R Barshes, Erin E Agee, Christine A O'Mahoney, F Charles Brunicardi, John A Goss.   

Abstract

Diabetes mellitus is a leading cause of morbidity and mortality in the Western world. Currently, the only forms of beta-cell replacement are whole organ pancreas transplantation and pancreatic islet transplantation. Whole organ transplantation has demonstrated benefits in prevention and reversal of diabetic complications with sustainable long-term outcomes. Pancreatic islet transplantation continues to be a field that needs further study to ascertain the true benefit of islet transplantation for diabetic complications. This can only be achieved with improvement in long-term islet allograft survival.

Entities:  

Mesh:

Year:  2006        PMID: 16879786     DOI: 10.1007/s11892-006-0068-x

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  33 in total

1.  Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation.

Authors:  Muhammad M Hafiz; Raquel N Faradji; Tatiana Froud; Antonello Pileggi; David A Baidal; Pablo Cure; Gaston Ponte; Raffaella Poggioli; Agustin Cornejo; Shari Messinger; Camillo Ricordi; Rodolfo Alejandro
Journal:  Transplantation       Date:  2005-12-27       Impact factor: 4.939

2.  Effects of pancreas-kidney transplantation on diabetic retinopathy.

Authors:  Rosa Giannarelli; Alberto Coppelli; Mariasole Sartini; Michele Aragona; Ugo Boggi; Fabio Vistoli; Gaetano Rizzo; Stefano Del Prato; Franco Mosca; Piero Marchetti
Journal:  Transpl Int       Date:  2005-05       Impact factor: 3.782

3.  Transplantation of intact pancreatic islets in rats.

Authors:  W F Ballinger; P E Lacy
Journal:  Surgery       Date:  1972-08       Impact factor: 3.982

4.  The beneficial effects of pancreas transplant alone on diabetic nephropathy.

Authors:  Alberto Coppelli; Rosa Giannarelli; Fabio Vistoli; Stefano Del Prato; Gaetano Rizzo; Franco Mosca; Ugo Boggi; Piero Marchetti
Journal:  Diabetes Care       Date:  2005-06       Impact factor: 19.112

5.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Authors:  John M Lachin; Saul Genuth; Patricia Cleary; Matthew D Davis; David M Nathan
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

Review 6.  Diagnosis and management of diabetic neuropathy.

Authors:  Bruce A Perkins; Vera Bril
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

7.  Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review.

Authors:  N R Barshes; T Lee; S Goodpasture; F C Brunicardi; R Alejandro; C Ricordi; G Soltes; M Barth; D Hamilton; J A Goss
Journal:  Transplant Proc       Date:  2004-05       Impact factor: 1.066

8.  Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center.

Authors:  John A Goss; Sarah E Goodpastor; F Charles Brunicardi; Merle H Barth; George D Soltes; Alan J Garber; Dale J Hamilton; Rodolfo Alejandro; Camillo Ricordi
Journal:  Transplantation       Date:  2004-02-15       Impact factor: 4.939

9.  Early improvement in cardiac function occurs for pancreas-kidney but not diabetic kidney-alone transplant recipients.

Authors:  A O Gaber; S el-Gebely; P Sugathan; D S Elmer; D K Hathaway; R B McCully; M H Shokouh-Amiri; B S Burlew
Journal:  Transplantation       Date:  1995-04-27       Impact factor: 4.939

10.  Changes in liver enzymes after clinical islet transplantation.

Authors:  Ehab Rafael; Edmond A Ryan; Breay W Paty; Jose Oberholzer; Sharleen Imes; Peter Senior; Charlotte McDonald; Jonathan R T Lakey; A M James Shapiro
Journal:  Transplantation       Date:  2003-11-15       Impact factor: 4.939

View more
  8 in total

Review 1.  Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome.

Authors:  A M James Shapiro
Journal:  Rev Diabet Stud       Date:  2012-12-28

2.  C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cells.

Authors:  V Cifarelli; X Geng; A Styche; R Lakomy; M Trucco; P Luppi
Journal:  Diabetologia       Date:  2011-07-20       Impact factor: 10.122

3.  Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway.

Authors:  P Luppi; V Cifarelli; H Tse; J Piganelli; M Trucco
Journal:  Diabetologia       Date:  2008-05-21       Impact factor: 10.122

Review 4.  Pancreas transplant alone: a procedure coming of age.

Authors:  Rainer W G Gruessner; Angelika C Gruessner
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

Review 5.  Proinsulin C-peptide: friend or foe in the development of diabetes-associated complications?

Authors:  Lina Nordquist; M Johansson
Journal:  Vasc Health Risk Manag       Date:  2008

6.  Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action.

Authors:  Lina Nordquist; Fredrik Palm; Bradley T Andresen
Journal:  Biologics       Date:  2008-09

7.  The Impaired Bioenergetics of Diabetic Cardiac Microvascular Endothelial Cells.

Authors:  Haitao Zhang; Yan Shen; Il-Man Kim; Neal L Weintraub; Yaoliang Tang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-14       Impact factor: 5.555

Review 8.  C-Peptide as a Therapy for Type 1 Diabetes Mellitus.

Authors:  Rachel L Washburn; Karl Mueller; Gurvinder Kaur; Tanir Moreno; Naima Moustaid-Moussa; Latha Ramalingam; Jannette M Dufour
Journal:  Biomedicines       Date:  2021-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.